A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer (NICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01249352
Recruitment Status : Completed
First Posted : November 29, 2010
Last Update Posted : January 6, 2014
Information provided by:
Eurofarma Laboratorios S.A.